Literature DB >> 6380433

The use of stabilized human umbilical vein for femoropopliteal bypass. Experience with 133 operations with 5-year follow-up.

S A Hirsch, F Jarrett.   

Abstract

One hundred thirty-three femoropopliteal bypasses using stabilized human umbilical vein were performed in 116 patients during a 5-year period. The indications for operation were claudication in 35% and limb salvage in 65%. There were eight deaths in the postoperative period, all due to myocardial infarctions, and all occurring in patients operated upon for limb salvage. Patients operated upon for claudication had a cumulative patency rate of 83% at 1 year and 63.5% at 5 years, while patients operated upon for limb salvage had patency rates of 66% and 50% at 1 and 5 years. Diabetics had a patency rate of 69% at 5 years. The quality of arteriographic runoff was the leading determinant of patency in all groups. Two instances of aneurysmal degeneration of the graft were seen, both 5 years after implantation, and two graft infections were observed.

Entities:  

Mesh:

Year:  1984        PMID: 6380433      PMCID: PMC1250436          DOI: 10.1097/00000658-198408000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  Autologus saphenous vein femoropopliteal bypass: analysis of 298 cases.

Authors:  B S Cutler; J E Thompson; L J Kleinsasser; G K Hempel
Journal:  Surgery       Date:  1976-03       Impact factor: 3.982

2.  Autogenous venous grafts ten years later.

Authors:  J A DeWeese; C G Rob
Journal:  Surgery       Date:  1977-12       Impact factor: 3.982

3.  The early results of reconstruction of the femoral artery with a Gore-Tex prosthesis.

Authors:  A R Hearn; D Charlesworth
Journal:  Surgery       Date:  1979-06       Impact factor: 3.982

4.  Durability of femoropopliteal reconstructions. Endarterectomy versus vein bypass grafts.

Authors:  R C Darling; R R Linton
Journal:  Am J Surg       Date:  1972-04       Impact factor: 2.565

5.  Autogenous vein grafting in femoropopliteal atherosclerosis: the limits of its effectiveness.

Authors:  D E Szilagyi; J H Hageman; R F Smith; J P Elliott; F Brown; P Dietz
Journal:  Surgery       Date:  1979-12       Impact factor: 3.982

6.  Human umbilical cord. A new source for vascular prosthesis.

Authors:  H Dardik; I M Ibrahim; R Baier; S Sprayregen; M Levy; I I Dardik
Journal:  JAMA       Date:  1976-12-20       Impact factor: 56.272

7.  Long-term results of 474 arterial reconstructions for severely ischemic limbs: a fourteen year follow-up.

Authors:  F A Reichle; K P Rankin; R R Tyson; A J Finestone; C Shuman
Journal:  Surgery       Date:  1979-01       Impact factor: 3.982

8.  Successful arterial substitution with modified human umbilical vein.

Authors:  H Dardik; I I Dardik
Journal:  Ann Surg       Date:  1976-03       Impact factor: 12.969

9.  A randomized clinical trial of PTFE versus human umbilical vein for femoropopliteal bypass surgery. Preliminary results.

Authors:  J H Eickhoff; H J Buchardt Hansen; A Brommé; B F Ericsson; K F Kordt; C Mouritzen; H O Myhre; L Norgren; H Rostad; A Trippestad
Journal:  Br J Surg       Date:  1983-02       Impact factor: 6.939

10.  Comparison of expanded polytetrafluroethylene and autologous saphenous vein grafts in high risk arterial reconstructions for limb salvage.

Authors:  F J Veith; C M Moss; S C Fell; C Montefusco; B A Rhodes; H Haimovici
Journal:  Surg Gynecol Obstet       Date:  1978-11
View more
  1 in total

1.  Biodegradation of glutaraldehyde-tanned human umbilical vein grafts.

Authors:  O Sato; H Okamoto; A Takagi; T Miyata; Y Takayama
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.